Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive - S&P Global Ratings’ Credit Research

Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive

Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive - S&P Global Ratings’ Credit Research
Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive
Published Aug 03, 2021
3 pages (1454 words) — Published Aug 03, 2021
Price Free  |  Buy this Report Now

About This Report

  
Abstract:

NEW YORK (S&P Global Ratings) Aug. 3, 2021--Bausch Health Cos. Inc. (BHC; 'B+/Negative') reported solid second-quarter results, which are upstaged by two major announcements. The Solta Medical IPO announcement was a surprise to us and added more uncertainties to the Bausch + Lomb (B+L) spin-off. Additionally, the expected leadership announcement for Bausch Pharma provided some early clarity to the market, though the company has yet to detail its strategy. We view the operating performance as in line with expectations, given solid recovery from the COVID-19 pandemic.

  
Report Type:

Bulletin

Ticker
VRX
Issuer
Bausch Health Cos. Inc.
GICS
Pharmaceuticals (35202010)
Sector
Global Issuers
Country
Canada
Region
Canada
Format:
PDF Adobe Acrobat
Buy Now

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive" Aug 03, 2021. Alacra Store. May 22, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Bulletin-Solta-IPO-Adds-Uncertainty-To-Bausch-Health-Cos-Inc-s-Metrics-Bausch-Pharma-Leadership-Announcement-Is-A-Positive-2698993>
  
APA:
S&P Global Ratings’ Credit Research. (). Bulletin: Solta IPO Adds Uncertainty To Bausch Health Cos. Inc.'s Metrics; Bausch Pharma Leadership Announcement Is A Positive Aug 03, 2021. New York, NY: Alacra Store. Retrieved May 22, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Bulletin-Solta-IPO-Adds-Uncertainty-To-Bausch-Health-Cos-Inc-s-Metrics-Bausch-Pharma-Leadership-Announcement-Is-A-Positive-2698993>
  
Free
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.